Clorox Q3 EPS Tops Estimates but Shares Slump 9% on Category Weakness
Clorox beat Q3 EPS estimates and maintained flat net sales while executing cost savings across operations. After closing its GOJO unit and citing greater margin pressure, the company trimmed FY26 guidance, and shares slumped 9% as analysts warned of kitty litter and salad dressing weakness.
1. Q3 EPS Beat Driven by Cost Cuts
Clorox beat Q3 EPS estimates by implementing broad cost-saving measures that offset flat net sales, delivering positive bottom-line results despite stagnant volume trends.
2. Category Weakness Triggers Share Decline
Shares slumped 9% following analyst warnings of underperformance in the kitty litter and salad dressing segments, as the company noted soft consumer demand and competitive pricing pressures.
3. FY26 Guidance Revised After GOJO Closure
The company trimmed its full-year FY26 outlook post strategic shutdown of its GOJO business, reflecting heightened margin pressure and restructuring costs, while projecting modest organic sales growth.
4. Analyst Downgrades and Forecast Adjustments
Multiple analysts cut earnings estimates and price targets, citing inventory destocking and uneven category demand as key factors behind the downward revisions.